HAE - Haemonetics Corporation

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5 6.33B
Enterprise Value 3 6.45B
Trailing P/E 118.64
Forward P/E 1 33.90
PEG Ratio (5 yr expected) 1 3.50
Price/Sales (ttm) 6.54
Price/Book (mrq) 9.43
Enterprise Value/Revenue 3 6.67
Enterprise Value/EBITDA 6 34.23

Trading Information

Stock Price History

Beta (3Y Monthly) 0.69
52-Week Change 3 26.34%
S&P500 52-Week Change 3 7.27%
52 Week High 3 123.88
52 Week Low 3 80.24
50-Day Moving Average 3 112.58
200-Day Moving Average 3 96.70

Share Statistics

Avg Vol (3 month) 3 533.48k
Avg Vol (10 day) 3 315.68k
Shares Outstanding 5 51.26M
Float 50.85M
% Held by Insiders 1 0.50%
% Held by Institutions 1 100.28%
Shares Short (Jun 28, 2019) 4 1.43M
Short Ratio (Jun 28, 2019) 4 2.58
Short % of Float (Jun 28, 2019) 4 4.27%
Short % of Shares Outstanding (Jun 28, 2019) 4 2.79%
Shares Short (prior month May 31, 2019) 4 1.08M

Dividends & Splits

Forward Annual Dividend Rate 4 N/A
Forward Annual Dividend Yield 4 N/A
Trailing Annual Dividend Rate 3 N/A
Trailing Annual Dividend Yield 3 N/A
5 Year Average Dividend Yield 4 N/A
Payout Ratio 4 0.00%
Dividend Date 3 N/A
Ex-Dividend Date 4 N/A
Last Split Factor (new per old) 2 1/2
Last Split Date 3 Dec 3, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 30, 2019
Most Recent Quarter (mrq) Mar 30, 2019

Profitability

Profit Margin 5.69%
Operating Margin (ttm) 10.82%

Management Effectiveness

Return on Assets (ttm) 5.21%
Return on Equity (ttm) 7.75%

Income Statement

Revenue (ttm) 967.58M
Revenue Per Share (ttm) 18.78
Quarterly Revenue Growth (yoy) 6.70%
Gross Profit (ttm) 438.71M
EBITDA 188.53M
Net Income Avi to Common (ttm) 55.02M
Diluted EPS (ttm) 1.04
Quarterly Earnings Growth (yoy) 75.40%

Balance Sheet

Total Cash (mrq) 169.35M
Total Cash Per Share (mrq) 3.31
Total Debt (mrq) 350.12M
Total Debt/Equity (mrq) 52.42
Current Ratio (mrq) 2.44
Book Value Per Share (mrq) 13.09

Cash Flow Statement

Operating Cash Flow (ttm) 159.28M
Levered Free Cash Flow (ttm) -1.21M